Excess sugars in the diabetic milieu induce proteins with slow turnover to accumulate yellow and fluorescent modifications which may serve as markers for a person's past glycemic history and potential for future complications. The objective is to elucidate the biochemical nature of skin auto-fluorescence that has been widely used in the diabetes literature as a presumptive and recently proposed noninvasive marker for advanced glycation end-product """"""""AGE""""""""-formation. In 1993, this laboratory was able to obtain skin biopsies from 216 participants with type 1 diabetes in the DCCT study and quantitate various AGE markers of glycemic exposure and damage. Strong correlations between skin levels and severity of micro-vascular disease as well as decrease in skin levels of AGEs were noted in subjects undergoing intensive vs. conventional therapy for hyperglycemia. Four and eight years later, these associations were reevaluated in the EDIC trial, and to our surprise, several of the markers were found to predict the risk of progression of retinopathy and nephropathy. Most surprisingly, however, only one marker of unknown chemical origin named """"""""collagen-linked long-wavelength fluorescence"""""""" (""""""""LW') was found to predict the risk of calcium deposition and atherosclerosis progression as measured by coronary artery calcium deposition """"""""CAC"""""""" at all CAC scores; i.e., >0, >100, and >200.
Specific aims are: (1) elucidate the structure of the novel marker of atherosclerosis progression yet elusive fluorophore """"""""LW"""""""" in skin ; (2) To quantitate LW in skin biopsy collagen obtained at the time of DCCT closeout, and determine its ability to predict risk of macro- and micro-vascular disease in the EDIC; (3) To determine the quantitative relationship between LW in skin and carotid artery and the in situ relationship between LW formation and calcium deposition in autopsy tissue from individuals with diabetes and end-stage renal disease; and (4) to determine the in vivo mechanism of LW-1 formation and prevention of formation in animal models of diabetes and hyperlipidemia. Because LW fluorescence can be monitored non-invasively in cornea and skin, this research may have broad implications for the development of novel methodologies for assessment of the risk for macro-vascular disease progression in diabetes. ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DK079432-02
Application #
7474782
Study Section
Special Emphasis Panel (ZDK1-GRB-N (M1))
Program Officer
Jones, Teresa L Z
Project Start
2007-08-01
Project End
2010-07-31
Budget Start
2008-08-01
Budget End
2010-07-31
Support Year
2
Fiscal Year
2008
Total Cost
$227,115
Indirect Cost
Name
Case Western Reserve University
Department
Pathology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Sell, David R; Nemet, Ina; Liang, Zhili et al. (2018) Evidence of glucuronidation of the glycation product LW-1: tentative structure and implications for the long-term complications of diabetes. Glycoconj J 35:177-190
Roshandel, Delnaz; Klein, Ronald; Klein, Barbara E K et al. (2016) New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins. Diabetes 65:2060-71
Sell, David R; Sun, Wanjie; Gao, Xiaoyu et al. (2016) Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes. Cardiovasc Diabetol 15:30
Monnier, Vincent M; Sun, Wanjie; Gao, Xiaoyu et al. (2015) Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovasc Diabetol 14:118
Genuth, Saul; Sun, Wanjie; Cleary, Patricia et al. (2015) Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 64:266-78
Gopal, P; Gosker, H R; Theije, C C de et al. (2015) Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice. Biochim Biophys Acta 1852:992-1000
Fessel, Gion; Li, Yufei; Diederich, Vincent et al. (2014) Advanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffness. PLoS One 9:e110948
Eny, Karen M; Lutgers, Helen L; Maynard, John et al. (2014) GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence. Diabetologia 57:1623-34
Monnier, Vincent M; Sun, Wanjie; Sell, David R et al. (2014) Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clin Chem Lab Med 52:21-32
Monnier, Vincent M; Sell, David R; Strauch, Christopher et al. (2013) The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. J Diabetes Complications 27:141-9

Showing the most recent 10 out of 13 publications